Project Details
Description
HM2014-24: AN OPEN-LABEL PHASE 2 PROSPECTIVE,RANDOMIZED, CONTROLLED STUDY OF CLT-008 MYELOID PROGENITOR CELLS AS A SUPPORTIVE CARE MEASURE DURING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA
| Status | Finished |
|---|---|
| Effective start/end date | 4/21/15 → 12/31/18 |
Funding
- CELLERANT THERAPEUTICS, INC.
- U.S. DEPARTMENT OF HEALTH & HUMAN SVCS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.